Compound information
- Natural Products
- ZC1894584
- Molecular Formula
- C18H20ClN3O2
- Molecular Weight
- 345.12440456 g/mol
- Structure
-
- IUPAC Name
- N-(4-chlorophenyl)-4-[(3-hydroxyphenyl)methyl]piperazine-1-carboxamide
- InChI
- InChI=1S/C18H20ClN3O2/c19-15-4-6-16(7-5-15)20-18(24)22-10-8-21(9-11-22)13-14-2-1-3-17(23)12-14/h1-7,12,23H,8-11,13H2,(H,20,24)
- InChI Key
- PPQGDDLNQINKKW-UHFFFAOYSA-N
- SMILES
- O=C(Nc1ccc(Cl)cc1)N1CCN(Cc2cccc(O)c2)CC1
- Source
- ZINC000059916548
Warheads
- Urea carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 24 | Ring Count | 3 |
Heteroatom Count | 6 | Rotatable Bond Count | 3 |
Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 2 |
Topological Polar Surface Area | 55.81 Å2 | LogP | 3.123 |
LogS | -3.33 | LogD | 3.561 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.719 | Pgp substrate | 0.905 |
HIA | 0.968 | F20 % | 0.865 |
F30 % | 0.781 | Caco-2 | -4.91 |
MDCK | -5.364 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.761 | PPB | 89.306 |
VD | 1.365 | Fu | 0.727 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.049 | CYP1A2 substrate | 0.772 |
CYP2A6 substrate | 0.767 | CYP2B6 substrate | 0.605 |
CYP2C19 inhibitor | 0.899 | CYP2C19 substrate | 0.908 |
CYP2C8 substrate | 0.899 | CYP2C9 inhibitor | 0.488 |
CYP2C9 substrate | 0.638 | CYP2D6 inhibitor | 0.97 |
CYP2D6 substrate | 0.996 | CYP2E1 substrate | 0.842 |
CYP3A4 inhibitor | 0.617 | CYP3A4 substrate | 0.931 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.915 | CL | 13.829 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.988 | Hepatotoxicity | 0.841 |
Mutagenicity | 0.001 | Rat Oral Acute Toxicity | 0.775 |
FDAMDD | 0.535 | Skin Sensitization | 0.959 |
Carcinogenicity | 0.034 | Eye Corrosion | 0.001 |
Eye Irritation | 0.004 | Respiratory Toxicity | 0.912 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.411 | IGC50 | 3.617 |
LC50FM | 2.962 | LC50DM | 0.277 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.374 | NR-AR-LBD | 0.203 |
NR-AhR | 0.794 | NR-Aromatase | 0.025 |
NR-ER | 0.417 | NR-ER-LBD | 0.563 |
NR-PPAR-gamma | 0.176 | SR-ARE | 0.907 |
SR-ATAD5 | 0.473 | SR-HSE | 0.183 |
SR-MMP | 0.604 | SR-p53 | 0.361 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.